We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Arguments Begin in Appeal Of ReGen Lawsuit against FDA
Arguments Begin in Appeal Of ReGen Lawsuit against FDA
Attorneys for Ivy Sports Medicine told a federal judge Tuesday that the FDA did not have authority to reconsider and rescind a classification decision on ReGen Biologics’ Menaflex collagen scaffold device.